Comparison Of Eosinophil Counts In Copd Group B And Group E Patients
Downloads
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease associated with chronic inflammation due to exposure to toxins and one of inflammation biomarkers is eosinophil counts which found to be increased in COPD cases and also associated with patient outcome. Aims : This research aims to analyze the differences of eosinophil counts in COPD patients either Group B or Group E at Prof. Dr. Chairuddin Panusunan Lubis Hospital, North Sumatra. Material and Methods: This is an observational analytical study with case-control design. Data were obtained retrospectively from medical records, with the main variable is eosinophil counts obtained from routine blood tests. Additional variables included gender, age, smoking history, level of shortness of breath (mMRC), history of exacerbations, body mass index (BMI), and education level. Bivariate analysis used the T-independent test for normally distributed data and Mann Whitney test for non-normally distributed data, p-value <0.05 indicates statistically significant results. Results: Most of COPD patient either in Group B or Group D was a heavy smoker with obesity type 2 and shortness of breath which indicated by a high mMRC score. Mean eosinophils values in COPD Group B patients was 248,677±294,739 while in COPD Group E patients it was 151,290±190,416. Analysis with T- Independent -test to compare eosinophil counts between Group B and Group E showed a statistically significant difference, with a p-value of 0.000 (p <0.05). Conclusion : COPD group B patients have a higher number of eosinophils than COPD group E which indicated a significant inflammatory process in group B, while more stable diseases in group E.
Copyright (c) 2025 Anita Fitriani Siregar, Pandiaman Pandia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
